Quick Answer
Anika Therapeutics, Inc. reported Total Assets of $190.27 million for fiscal year 2025.
Anika Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $190.27M | -6.2% |
| 2024 | $202.74M | -25.1% |
| 2023 | $270.63M | -22.5% |
| 2022 | $349.13M | +0.5% |
| 2021 | $347.54M | -4.9% |
| 2020 | $365.61M | +10.6% |
| 2019 | $330.71M | +18.5% |
| 2018 | $278.99M | -1.3% |
| 2017 | $282.62M | +17.6% |
| 2016 | $240.25M | +1.9% |
| 2015 | $235.75M | +22.3% |
| 2014 | $192.81M | +23.6% |
| 2013 | $156.04M | +9.8% |
| 2012 | $142.07M | +6.9% |
| 2011 | $132.84M | +3.0% |
| 2010 | $128.94M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $189.44M | -18.1% | +0.9% |
| June 30, 2025 | $187.68M | -28.5% | -1.5% |
| March 31, 2025 | $190.60M | -27.7% | -6.0% |
| December 31, 2024 | $202.74M | -25.1% | -12.4% |
| September 30, 2024 | $231.41M | -29.5% | -11.9% |
| June 30, 2024 | $262.65M | -20.1% | -0.4% |
| March 31, 2024 | $263.74M | -22.2% | -2.5% |
| December 31, 2023 | $270.63M | -22.5% | -17.5% |
- Anika Therapeutics, Inc. showed a decrease of -6.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Anika Therapeutics, Inc.’s total assets has grown by 47.6% (from $128.94 million to $190.27 million).
- The most recent figure is from Anika Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: